Empowering Patients During Active Monitoring for CLL
BeOne and the CLL Advocates Network have identified three key needs in the “active monitoring” phase of treatment. Watch hematologist Dr. Ben Kennedy explain.
“Active monitoring starts with active listening, because the whole active monitoring process is about that mutual understanding of the impact of a disease on an individual.”
How Best to Support Those in “Active Monitoring” for CLL
Many patients don’t start treatment right after a chronic lymphocytic leukemia (CLL) diagnosis. Instead, they enter what’s called “active monitoring” or “watch and wait”. BeOne Medicines and CLL Advocates Network have issued a call to action to better support those whose disease is being monitored for progression. It highlights the need for:
- Communication with health care providers
- Access to trustworthy information
- Peer support
Read the full report here. Or, watch Peter describe how he learned to cope during active monitoring.
